Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02078258
Other study ID # 1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date July 2015

Study information

Verified date March 2019
Source Hunan Normal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, we test whether a two-week 8-session neutral attention bias modification (ABM) training and a two-week 4-session positive ABM could reduce depressive symptoms relative to placebo controls in adolescents with major depressive disorder at posttraining and follow-ups during one year.


Description:

Depression is a common health problem in adolescents. Negative attentional bias has been theorized to play a critical role in the onset and maintenance of depression, suggesting that reduction of such biases may treat symptoms of depression. Recent studies have shown that attention bias modification(ABM) training could reduce depressive symptoms in both dysphoria and previously depressed adult patients.To test the effectiveness of ABM training on the treatment of depressive symptoms in depressed adolescents, we designed a randomized, double-blind, placebo controlled trial in adolescents with major depressive disorder(MDD).


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date July 2015
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender All
Age group 11 Years to 19 Years
Eligibility Inclusion Criteria:

- Meet the major depression disorder's criteria

Exclusion Criteria:

- bipolar disorder, schizophrenia or organic mental disorder;

- any concurrent psychotherapy;

- any concurrent psychotropic medication.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
ABMT
During a two-week period, 8 sessions of a modified dot probe task for attentional bias modification training (ABMT) condition, 8 sessions of a classic dot probe task for placebo training (PT) condition.

Locations

Country Name City State
China Department of Psychology, Hunan Normal University Changsha Hunan

Sponsors (1)

Lead Sponsor Collaborator
Hunan Normal University

Country where clinical trial is conducted

China, 

References & Publications (1)

Yang W, Zhang JX, Ding Z, Xiao L. Attention Bias Modification Treatment for Adolescents With Major Depression: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):208-18.e2. doi: 10.1016/j.jaac.2015.12.005. Epub 2015 Dec 23. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in depressive symptom number Depressive symptom accounts measured by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children. baseline, 7-week, 6-month follow-up
Primary Changes in depressive severity depressive severity measured by the construct interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children(K-SADS) baseline, 7-week, 6-month follow-up
Secondary Change of Self-report symptoms symptoms measured by the Center for Epidemiological Studies Depression Scale (CES-D), State-Trait Anxiety Inventory-Trait(STAI-T),Rumination Response Style(RRS),Suicidal Ideation Questionnaire(SIQ) baseline, 7-week, 6-, 12-month follow-up
Secondary Diagnostic status of major depressive disorder Assessed by the diagnostic interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children baseline, 7-week, 6-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT01894815 - Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial Phase 3
Completed NCT01726387 - Self-Management for Anxiety, Depression and Somatoform Disorders N/A
Completed NCT01361815 - Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) N/A